Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: Genotype-phenotype correlation

Typeset version

 

TY  - JOUR
  - Manning, B.M.a , Quane, K.A.a , Ording, H.b , Urwyler, A.c , Tegazzin, V.d , Lehane, M.e , O'Halloran, J.f , Hartung, E.g , Giblin, L.M.a , Lynch, P.J.a , Vaughan, P.a , Censier, K.c , Bendixen, D.b , Comi, G.h , Heytens, L.i , Monsieurs, K.i j , Fagerlund, T.k , Wolz, W.l , Heffron, J.J.A.a , Muller, C.R.l , McCarthy, T.V.a
  - 1998
  - American Journal of Human Genetics
  - Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: Genotype-phenotype correlation
  - Validated
  - ()
  - 62
  - 3
  - 599
  - 609
  - Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggered in genetically predisposed individuals by common anesthetics and muscle relaxants. The ryanodine receptor (RYR1) is mutated in a number of MH pedigrees, some members of which also have central core disease (CCD), an inherited myopathy closely associated with MH. Mutation screening of 6 kb of the RYR1 gene has identified four adjacent novel mutations, C6487T, G6488A, G6502A, and C6617T, which result in the amino acid alterations Arg2163Cys, Arg2163His, Val2168Met, and Thr2206Met, respectively. Collectively, these mutations account for 11% of MH cases and identify the gene segment 6400-6700 as a mutation hot spot. Correlation analysis of the in vitro contracture-test data available for pedigrees bearing these and other RYR1 mutations showed an exceptionally good correlation between caffeine threshold and tension values, whereas no correlation was observed between halothane threshold and tension values. This finding has important ramifications for assignment of the MH-susceptible phenotype, in genotyping studies, and indicates that assessment of recombinant individuals on the basis of caffeine response is justified, whereas assessment on the basis of halothane response may be problematic. Interestingly, the data suggest a link between the caffeine threshold and tension values and the MH/CCD phenotype.
  - http://www.scopus.com/inward/record.url?eid=2-s2.0-17344368549;partnerID=40;md5=877109221242919c07cc038af6289515
DA  - 1998/NaN
ER  - 
@article{V153446169,
   = {Manning,  B.M.a  and  Quane,  K.A.a  and  Ording,  H.b  and  Urwyler,  A.c  and  Tegazzin,  V.d  and  Lehane,  M.e  and  O'Halloran,  J.f  and  Hartung,  E.g  and  Giblin,  L.M.a  and  Lynch,  P.J.a  and  Vaughan,  P.a  and  Censier,  K.c  and  Bendixen,  D.b  and  Comi,  G.h  and  Heytens,  L.i  and  Monsieurs,  K.i j  and  Fagerlund,  T.k  and  Wolz,  W.l  and  Heffron,  J.J.A.a  and  Muller,  C.R.l  and  McCarthy,  T.V.a },
   = {1998},
   = {American Journal of Human Genetics},
   = {Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: Genotype-phenotype correlation},
   = {Validated},
   = {()},
   = {62},
   = {3},
  pages = {599--609},
   = {{Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggered in genetically predisposed individuals by common anesthetics and muscle relaxants. The ryanodine receptor (RYR1) is mutated in a number of MH pedigrees, some members of which also have central core disease (CCD), an inherited myopathy closely associated with MH. Mutation screening of 6 kb of the RYR1 gene has identified four adjacent novel mutations, C6487T, G6488A, G6502A, and C6617T, which result in the amino acid alterations Arg2163Cys, Arg2163His, Val2168Met, and Thr2206Met, respectively. Collectively, these mutations account for 11% of MH cases and identify the gene segment 6400-6700 as a mutation hot spot. Correlation analysis of the in vitro contracture-test data available for pedigrees bearing these and other RYR1 mutations showed an exceptionally good correlation between caffeine threshold and tension values, whereas no correlation was observed between halothane threshold and tension values. This finding has important ramifications for assignment of the MH-susceptible phenotype, in genotyping studies, and indicates that assessment of recombinant individuals on the basis of caffeine response is justified, whereas assessment on the basis of halothane response may be problematic. Interestingly, the data suggest a link between the caffeine threshold and tension values and the MH/CCD phenotype.}},
   = {http://www.scopus.com/inward/record.url?eid=2-s2.0-17344368549;partnerID=40;md5=877109221242919c07cc038af6289515},
  source = {IRIS}
}
AUTHORSManning, B.M.a , Quane, K.A.a , Ording, H.b , Urwyler, A.c , Tegazzin, V.d , Lehane, M.e , O'Halloran, J.f , Hartung, E.g , Giblin, L.M.a , Lynch, P.J.a , Vaughan, P.a , Censier, K.c , Bendixen, D.b , Comi, G.h , Heytens, L.i , Monsieurs, K.i j , Fagerlund, T.k , Wolz, W.l , Heffron, J.J.A.a , Muller, C.R.l , McCarthy, T.V.a
YEAR1998
MONTH
JOURNAL_CODEAmerican Journal of Human Genetics
TITLEIdentification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: Genotype-phenotype correlation
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORD
VOLUME62
ISSUE3
START_PAGE599
END_PAGE609
ABSTRACTMalignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggered in genetically predisposed individuals by common anesthetics and muscle relaxants. The ryanodine receptor (RYR1) is mutated in a number of MH pedigrees, some members of which also have central core disease (CCD), an inherited myopathy closely associated with MH. Mutation screening of 6 kb of the RYR1 gene has identified four adjacent novel mutations, C6487T, G6488A, G6502A, and C6617T, which result in the amino acid alterations Arg2163Cys, Arg2163His, Val2168Met, and Thr2206Met, respectively. Collectively, these mutations account for 11% of MH cases and identify the gene segment 6400-6700 as a mutation hot spot. Correlation analysis of the in vitro contracture-test data available for pedigrees bearing these and other RYR1 mutations showed an exceptionally good correlation between caffeine threshold and tension values, whereas no correlation was observed between halothane threshold and tension values. This finding has important ramifications for assignment of the MH-susceptible phenotype, in genotyping studies, and indicates that assessment of recombinant individuals on the basis of caffeine response is justified, whereas assessment on the basis of halothane response may be problematic. Interestingly, the data suggest a link between the caffeine threshold and tension values and the MH/CCD phenotype.
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URLhttp://www.scopus.com/inward/record.url?eid=2-s2.0-17344368549;partnerID=40;md5=877109221242919c07cc038af6289515
DOI_LINK
FUNDING_BODY
GRANT_DETAILS